ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.68 USD
-0.85%
Updated:
Apr 23, 2024
ADC Therapeutics SA
Retained Earnings
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Retained Earnings Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Retained Earnings
$-1.3B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Retained Earnings
CHf-316.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Retained Earnings
$-999.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Retained Earnings
CHf41.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Retained Earnings
CHf-2.8B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-188%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Retained Earnings
CHf53.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Retained Earnings?
Retained Earnings
-1.3B
USD
-1.3B
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Retained Earnings amounts to -1.3B USD.
What is ADC Therapeutics SA's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-33%
-33%
Over the last year, the Retained Earnings growth was -44%. The average annual Retained Earnings growth rates for ADC Therapeutics SA have been -27% over the past three years , -33% over the past five years .
You don't have any saved screeners yet
